According to the Zhitong Finance App, Zhaoyan New Pharmaceutical (603127.SH) announced that as of the date of this announcement, Zhou Zhiwen, one of the actual controllers, reduced the company's A-share holdings by 4.4739 million shares through bulk transactions and centralized bidding transactions, accounting for 0.84% of the company's total share capital. This reduction took more than half of the time.
昭衍新药(603127.SH)实控人之一周志文累计减持447.39万股
Zhou Zhiwen, one of the actual controllers of Zhaoyan Pharmaceutical (603127.SH), reduced his holdings by 4.4739 million shares
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.